Intravenous & Topical Fluids

{
  "id": "060102-2026",
  "tag": [
    "tender"
  ],
  "date": "2026-06-26T09:07:57+01:00",
  "ocid": "ocds-h6vhtk-06bda2",
  "buyer": {
    "id": "GB-FTS-322",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
  },
  "links": [
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000830029"
    }
  ],
  "tender": {
    "id": "NP30026",
    "lots": [
      {
        "id": "1",
        "title": "Glucose 5%, Sodium Chloride 0.9% 50ml, 100ml, 250ml Infusion Bags",
        "value": {
          "amount": 4805635,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This Framework Agreement includes the option to extend for period(s) up to a combined total of twenty-four (24) months, upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Glucose 5%, Sodium Chloride 0.9% 50ml, 100ml, 250ml Infusion Bags to NHS Scotland.  The Authority  intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of three (3) Framework Participants will be awarded to each line. Full details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Continuity of Supply",
              "type": "quality",
              "description": "15%"
            },
            {
              "name": "Sustainability",
              "type": "quality",
              "description": "10%"
            },
            {
              "type": "price",
              "description": "75%"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "2",
        "title": "Needle Free Infusion Bags – various presentations",
        "value": {
          "amount": 20000,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This Framework Agreement includes the option to extend for period(s) up to a combined total of twenty-four (24) months, upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Needle Free Infusion Bags to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of three (3) Framework Participants will be awarded to each line. Full details can be found within the ITT",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Continuity of Supply",
              "type": "quality",
              "description": "15%"
            },
            {
              "name": "Sustainability",
              "type": "quality",
              "description": "10%"
            },
            {
              "type": "price",
              "description": "75%"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "3",
        "title": "Unlicensed Infusion Bags",
        "value": {
          "amount": 2158405,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This Framework Agreement includes the option to extend for period(s) up to a combined total of twenty-four (24) months, upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Unlicensed Infusion Bags to NHS Scotland in a range of presentations. The Authority  intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of three (3) Framework Participants will be awarded to each line. Full details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Continuity of Supply",
              "type": "quality",
              "description": "15%"
            },
            {
              "name": "Sustainability",
              "type": "quality",
              "description": "10%"
            },
            {
              "type": "price",
              "description": "75%"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "4",
        "title": "A range of Licensed Infusion Bags",
        "value": {
          "amount": 666590,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This Framework Agreement includes the option to extend for period(s) up to a combined total of twenty-four (24) months, upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of a range of Licensed Infusion Bags to NHS Scotland in a range of presentations. The Authority  intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of three (3) Framework Participants will be awarded to each line. Full details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Continuity of Supply",
              "type": "quality",
              "description": "15%"
            },
            {
              "name": "Sustainability",
              "type": "quality",
              "description": "10%"
            },
            {
              "type": "price",
              "description": "75%"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "5",
        "title": "All other product lines (including Topical Fluids)",
        "value": {
          "amount": 17666120,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This Framework Agreement includes the option to extend for period(s) up to a combined total of twenty-four (24) months, upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of all other Intravenous & Topical Fluids and topical fluids to NHS Scotland. The Authority intends awarding each product line within this Lot to a single Framework Participant. Full details can be found within the ITT.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Continuity of Supply",
              "type": "quality",
              "description": "15%"
            },
            {
              "name": "Sustainability",
              "type": "quality",
              "description": "10%"
            },
            {
              "type": "price",
              "description": "75%"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014"
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "4",
        "relatedLot": "4",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "5",
        "relatedLot": "5",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "Intravenous & Topical Fluids",
    "value": {
      "amount": 39671652,
      "currency": "GBP"
    },
    "status": "active",
    "coveredBy": [
      "GPA"
    ],
    "bidOpening": {
      "date": "2026-07-27T12:00:00+01:00"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lotDetails": {
      "maximumLotsBidPerSupplier": null
    },
    "techniques": {
      "frameworkAgreement": {
        "maximumParticipants": 6
      },
      "hasFrameworkAgreement": true
    },
    "awardPeriod": {
      "startDate": "2026-07-27T12:00:00+01:00"
    },
    "description": "This Framework Agreement is for the supply of Intravenous & Topical Fluids to health boards across NHS Scotland. The Goods have been split into five (5) categories, each of which is identified as a \"Lot\". Full details of each Lot is contained in section II.2 of this notice.",
    "tenderPeriod": {
      "endDate": "2026-07-27T12:00:00+01:00"
    },
    "contractTerms": {
      "hasElectronicPayment": true,
      "hasElectronicOrdering": true,
      "electronicInvoicingPolicy": "allowed"
    },
    "hasRecurrence": false,
    "reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "bidValidityPeriod": {
        "durationInDays": 90
      }
    },
    "submissionMethod": [
      "electronicSubmission"
    ],
    "procurementMethod": "open",
    "selectionCriteria": {
      "criteria": [
        {
          "type": "suitability",
          "appliesTo": [
            "supplier"
          ],
          "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
        },
        {
          "type": "technical",
          "minimum": "a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender with the exclusion of Lot Three, should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(b) For Lot Three only Confirmation of existence of a valid and current UK Manufacturing 'Specials' License approved by the MHRA at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(c) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.\n(d) Confirmation that all devices tendered and associated ancillaries which are classed as medical devices will carry the appropriate declaration of conformity for the UK market and display a valid CE, CE UKNI or UKCA at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.",
          "appliesTo": [
            "supplier"
          ],
          "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL,PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender, with the exclusion of Lot Three.\n(b) For Lot Three only Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Manufacturing ‘Specials' licence approved by MHRA at the date of submission of the tender.\n(c) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender.\n(d) Potential Framework Participants must be able to demonstrate that all medical devices and associated ancillaries which are classed as medical devices tendered under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark at the date of submission of the tender."
        }
      ]
    },
    "mainProcurementCategory": "goods",
    "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-322",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
      },
      "contactPoint": {
        "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "email": "siobhan.ramage@nhs.scot",
        "telephone": "+44 1698794410"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk"
      }
    }
  ],
  "language": "en",
  "description": "The estimated value(s) referred to in Section II.1.5 & All Lots cover(s) the twenty-four (24) month contract duration and the twenty-four (24) month extension period of the framework agreement.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 31713. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nThe Statement of Requirements will detail the Community Benefit background and objectives. The contract will mandate that suppliers respond in its tender outlining current Community Benefits and proposals if successful and mandating that they support the overall Community Benefit concept and process including a contract and supplier management process post award.\n(SC Ref:830029)",
  "initiationType": "tender"
}